Home › Compare › GRNH vs JNJ

GRNH vs JNJ: Dividend Comparison 2026

GRNH yields 4000000.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GRNH wins by $4.994481689239762e+42M in total portfolio value
10 years
GRNH
GRNH
● Live price
4000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.994481689239762e+42M
Annual income
$4,994,236,078,782,737,000,000,000,000,000,000,000,000,000,000,000.00
Full GRNH calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — GRNH vs JNJ

📍 GRNH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGRNHJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GRNH + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GRNH pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GRNH
Annual income on $10K today (after 15% tax)
$340,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,245,100,666,965,326,000,000,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, GRNH beats the other by $4,245,100,666,965,326,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GRNH + JNJ for your $10,000?

GRNH: 50%JNJ: 50%
100% JNJ50/50100% GRNH
Portfolio after 10yr
$2.497240844619881e+42M
Annual income
$2,497,118,039,391,368,600,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GRNH
No analyst data
Altman Z
-25.6
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GRNH buys
0
JNJ buys
0
No recent congressional trades found for GRNH or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGRNHJNJ
Forward yield4000000.00% ✓2.13%
Annual dividend / share$2.00$5.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28% ✓
Portfolio after 10y$4.994481689239762e+42M$30.3K ✓
Annual income after 10y$4,994,236,078,782,737,000,000,000,000,000,000,000,000,000,000,000.00 ✓$4,689.40
Total dividends collected$4.994465620575748e+42M$15.4K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GRNH vs JNJ ($10,000, DRIP)

YearGRNH PortfolioGRNH Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$400,010,700$400,000,000.00$10,592$272.30+$400.00M → GRNH
2$14,954,099,039,486$14,953,671,028,037.38$11,289$357.73+$14954099.03M → GRNH
3$522,475,570,786,797,700$522,459,569,900,825,500.00$12,123$472.89+$522475570786.79M → GRNH
4$17,060,387,015,284,700,000,000$17,059,827,966,423,956,000,000.00$13,141$629.86+$17060387015284700.00M → GRNH
5$520,629,757,399,644,800,000,000,000$520,611,502,785,538,400,000,000,000.00$14,408$846.81+$520629757399644831744.00M → GRNH
6$14,848,629,939,995,690,000,000,000,000,000$14,848,072,866,155,271,000,000,000,000,000.00$16,021$1,151.60+$1.4848629939995692e+25M → GRNH
7$395,786,651,827,842,740,000,000,000,000,000,000$395,770,763,793,806,900,000,000,000,000,000,000.00$18,122$1,588.22+$3.9578665182784276e+29M → GRNH
8$9,859,464,902,403,675,000,000,000,000,000,000,000,000$9,859,041,410,686,219,000,000,000,000,000,000,000,000.00$20,930$2,228.20+$9.859464902403675e+33M → GRNH
9$229,542,483,200,980,940,000,000,000,000,000,000,000,000,000$229,531,933,573,535,350,000,000,000,000,000,000,000,000,000.00$24,792$3,191.91+$2.2954248320098093e+38M → GRNH
10$4,994,481,689,239,762,000,000,000,000,000,000,000,000,000,000,000$4,994,236,078,782,737,000,000,000,000,000,000,000,000,000,000,000.00$30,274$4,689.40+$4.994481689239762e+42M → GRNH

GRNH vs JNJ: Complete Analysis 2026

GRNH — Stock

GreenGro Technologies, Inc. designs, manufactures, and markets green eco-friendly vertical cultivation systems in the United States. It offers flux lighting products, table stands, nutrient mixers, home units, cloning systems, and tea brewers, as well as provides consulting and management services to its clients. The company also markets lights, fans, hoods, automatic watering systems, and nutrients under the GreenGro brand. GreenGro Technologies, Inc. offers its products to consumers and industrial cultivators through its Website. The company has a strategic alliance with Solaris Power Cells; and an alliance agreement with Organna LLC for CBD ventures division. The company, formerly known as Authoriszor, Inc., was founded in 1996 and is based in Anaheim, California.

Full GRNH Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this GRNH vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GRNH vs SCHDGRNH vs JEPIGRNH vs OGRNH vs KOGRNH vs MAINGRNH vs ABBVGRNH vs MRKGRNH vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.